Yarrow Bioscience YARW
NASDAQ YARW
$22.27 -1.33 (-5.64%)
At close: Oct 2, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) Asset Writedowns and Impairment (2020)

Updated

Yarrow Bioscience's Asset Writedowns and Impairment came in at $54.35 million for FY2020.

Analysis

Yarrow Bioscience (YARW) Asset Writedowns and Impairment (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Yarrow Bioscience 19.11 Mn -97.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 54.35 Mn
API Access

Yarrow Bioscience Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=YARW&period=max&api_key=YOUR_API_KEY